Iceland vs Sur: Previously treated cases tested for RR-/MDR-TB
Iceland
100.0%
in 2022
Sur
62.0%
in 2024
Iceland rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iceland
- Sur
How they compare
Iceland currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Iceland's figure about 1.6 times Sur's.
The two have swapped places 4 times across 7 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 1st and Sur ranks 1st of 180 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.0% | 100.0% | Iceland |
| 2010s | 62.5% | 39.0% | 23.5% | Iceland |
| 2020s | 100.0% | 80.0% | 20.0% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iceland or Sur?
- Iceland, at 100.0% against 62.0% in Sur as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iceland and Sur?
- 38.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Sur?
- 7 years are reported by both, from 2005 to 2022.
- How do Iceland and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.